beckley-clinical
Provides behavioral health care specializing in psychedelic-assisted therapies.
Company facts
- Founded
- 1998
- Employees
- 13
- Headquarters
- United States
- CEO
- Joshua Stevens
- Type
- Private
- Funding
- Funding Round · 2022
About
Beckley Clinical is a leader in behavioral health innovation, committed to delivering transformative outcomes through evidence-based drug-assisted therapies (DAT). Rooted in over 30 years of experience in psychedelic research, Beckley Clinical was founded to address the critical need for effective, accessible, and safe treatments for behavioral health conditions. The company currently specializes in Ketamine-Assisted Therapy (KAT) with plans to expand into psilocybin and MDMA-assisted therapies. Beckley Clinical combines cutting-edge pharmacologic interventions with comprehensive wraparound care to maximize patient outcomes. Their hybrid approach integrates in-clinic dosing for safety with telehealth-enabled preparation, integration, and support services. Their behavioral health providers specialize in treating major depressive disorder and Treatment Resistant Depression (TRD) using Transcranial Magnetic Stimulation (TMS) and psychedelic-assisted therapy (PAT). Beckley Clinical is committed to insurance-first access and accepts all major health plans to ensure broad accessibility to their innovative treatments.